Centro de Investigaciones Médicas y Desarrollo LC S.R.L

Buenos Aires, Buenos Aires F.D. 1113

0 studies enrolling now · 1 studies all time

What they study most

Urothelial Carcinoma

Studies at this site

• A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2 — Recruiting now